Dual effect of strontium ranelate: Stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro

Bone

Volumn 42, Issue 1, 2008, Pages 129-138

  Bonnelye, Edith ^a,b   Chabadel, Anne ^a   Saltel, Frédéric ^a   Jurdic, Pierre ^a  

^a University Lyon i   (France)

^b INSERM   (France)

Author keywords

Bone formation; Cytoskeleton; Osteoblast; Osteoclast; Strontium ranelate

Indexed keywords

ACTIN; ANABOLIC AGENT; BIOLOGICAL MARKER; STRONTIUM RANELATE;

ANIMAL CELL; ARTICLE; BONE CELL; BONE REMODELING; CALVARIA; CELL ASSAY; CELL DIFFERENTIATION; CELL DISRUPTION; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PROTEIN EXPRESSION; SPLEEN CELL;

EID: 37349123534     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.08.043     Document Type: Article

References (43)

1. Ammann P., Shen V., Robin B., Mauras Y., Bonjour J.P., and Rizzoli R. Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats. J Bone Miner Res 19 (2004) 2012-2020
2. Arlot M.E., Delmas P., Burt-Pichat B., Roux J.P., Portero N., and Meunier P.J. The effects of strontium ranelate on bone remodeling and bone safety assessed by histomorphometry in patients with postmenopausal osteoporosis. J Bone Miner Res 20 (2005) S22
3. Aubin J., and TJT. Mesenchymal stem cells and osteoblast differentiation. In: Bilezikian J.P., Raisz L.G., and Rodan G.A. (Eds). Principles of Bone Biology (2002), Academic Press, San Diego 59-81
4. Barbara A., Delannoy P., Denis B.G., and Marie P.J. Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells. Metabolism 53 (2004) 532-537
5. Baron R., and Tsouderos Y. In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation. Eur J Pharmacol 450 (2002) 11-17
6. Bellows C.G., Aubin J.E., Heersche J.N.M., and Antosz M.E. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 38 (1986) 143-154
7. Bonnelye E., Merdad L., Kung V., and Aubin J.E. The orphan nuclear estrogen receptor-related receptor (ERR) is expressed throughout osteoblast differentiation and regulates bone formation in vitro. J Cell Biol 153 (2001) 971-983
8. Boyle W.J., Simonet W.S., and Lacey D.L. Osteoclast differentiation and activation. Nature 423 (2003) 337-342
9. Brown E. Is the calcium receptor a molecular target for the actions of strontium on bone?. Osteoporosis Int 14 (2003) S34-S35
10. Canalis E., Hott M., Deloffre P., Tsouderos Y., and Marie P.J. The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 18 (1996) 517-523
11. Coulombe J., Faure H., Robin B., and Ruat M. In vitro effects of strontium ranelate on the extracellular calcium-sensing receptor. Biochem Biophys Res Commun 323 (2004) 1184-1190
12. Delaisse J.M., Andersen T.L., Engsig M.T., Henriksen K., Troen T., and Blavier L. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech 61 (2003) 504-513
13. Destaing O., Saltel F., Geminard J.C., Jurdic P., and Bard F. Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein. Mol Biol Cell 14 (2003) 407-416
14. Domon T., Yamazaki Y., Fukui A., Ohnishi Y., Takahashi S., Yamamoto T., and Wakita M. Three-dimensional distribution of the clear zone of migrating osteoclasts on dentin slices in vitro. Tissue Cell 34 (2002) 326-336
15. Fromigué O., Barbara A., Hay E., Petrel C.E., Traiffort E., Ruat M., et al. Strontium ranelate stimulates murine osteoblast replication independently of calcium sensing receptor-mediated ERK1/2 activation. Calcif Tissues Int 78 (2006) 147
16. Fuller K., Owens J.M., and Chambers T.J. Macrophage inflammatory protein-1 alpha and IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts. J Immunol 154 (1995) 6065-6072
17. Fuller K., Owens J.M., Jagger C.J., Wilson A., Moss R., and Chambers T.J. Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med 178 (1993) 1733-1744
18. Hott M., Deloffre P., Tsouderos Y., and Marie P.J. S12911-2 reduces bone loss induced by short-term immobilization in rats. Bone 33 (2003) 115-123
19. Jurdic P., Saltel F., Chabadel A., and Destaing O. Podosome and sealing zone: specificity of the osteoclast model. Eur J Cell Biol. 85 (2006) 195-202
20. Karsenty G. The complexities of skeletal biology. Nature 423 (2003) 316-318
21. Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 99 (2006) 1233-1239
22. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 (1998) 165-176
23. Marie P.J., Hott M., Modrowski D., De Pollak C., Guillemain J., Deloffre P., et al. An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 8 (1993) 607-615
24. Mentaverri R., Hurtel A.S., Kamel S., Robin B., and Brazier M. Extracellular concentrations of strontium directly stimulates osteoclast apoptosis. J Bone Miner Res 18 (2003) M237
25. Meunier P.J., Roux C., Seeman E., Ortolani S., Badurski J.E., Spector T.D., et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350 (2004) 459-468
26. Meunier P.J., Slosman D.O., Delmas P.D., Sebert J.L., Brandi M.L., Albanese C., et al. Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis-a 2-year randomized placebo controlled trial. J Clin Endocrinol Metab 87 (2002) 2060-2066
27. Pearse A. Emerson histochemistry, theoretical and applied. 3rd ed. (1960), Little, Brown, Boston, MA 999 pp.
28. Pi M., Faber P., Ekema G., Jackson P.D., Ting A., Wang N., et al. Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J Biol Chem 280 (2005) 40201-40209
29. Pi M., and Quarles L.D. A novel cation-sensing mechanism in osteoblasts is a molecular target for strontium. J Bone Miner Res 19 (2004) 862-869
30. Pilkington M.F., Sims S.M., and Dixon S.J. Wortmannin inhibits spreading and chemotaxis of rat osteoclasts in vitro. J Bone Miner Res 13 (1998) 688-694
31. Reginster J.Y., Seeman E., De Vernejoul M.C., Adami S., Compston J., Phenekos C., et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90 (2005) 2816-2822
32. Saltel F., Chabadel A., Zhao Y., Lafage-Proust M.H., Clezardin P., Jurdic P., et al. Transmigration, a new property of mature multinucleated osteoclasts. J Bone Miner Res 21 (2006) 1913-1923
33. Saltel F., Destaing O., Bard F., Eichert D., and Jurdic P. Apatite-mediated actin dynamics in resorbing osteoclasts. Mol Biol Cell 15 (2004) 5231-5241
34. Sato T., Foged N.T., and Delaisse J.M. The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors. J Bone Miner Res 13 (1998) 59-66
35. Shibutani T., Iwanaga H., Imai K., Kitago M., Doi Y., and Iwayama Y. Use of glass slides coated with apatite-collagen complexes for measurement of osteoclastic resorption activity. J Biomed Mater Res 50 (2000) 153-159
36. Silver I.A., Murrills R.J., and Etherington D.J. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 175 (1988) 266-276
37. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 (1997) 309-319
38. Takahashi N., Sasaki T., Tsouderos Y., and Suda T. S 12911-2 inhibits osteoclastic bone resorption in vitro. J Bone Miner Res 18 (2003) 1082-1087
39. Tsuda E., Goto M., Mochizuki S., Yano K., Kobayashi F., Morinaga T., et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234 (1997) 137-142
40. Turner R.T., Riggs B.L., and Spelsberg T.C. Skeletal effects of estrogen. Endocr Rev 15 (1994) 275-300
41. Vaananen H.K., Zhao H., Mulari M., and Halleen J.M. The cell biology of osteoclast function. J Cell Sci 113 (2000) 377-381
42. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 95 (1998) 3597-3602
43. Zhu L.L., Zaidi S., Peng Y., Zhou H., Moonga B.S., Blesius A., et al. Induction of a program gene expression during osteoblast differentiation with strontium ranelate. Biochem Biophys Res Commun 355 (2007) 307-311